Rainbow Childrens Medicare Experiences Revision in Stock Evaluation Amid Strong Performance Metrics
Rainbow Childrens Medicare has recently experienced a revision in its score by MarketsMojo, reflecting a shift in evaluation. The company continues to demonstrate strong management efficiency and a solid ability to service its debt, alongside impressive long-term growth metrics. Despite outperforming the market, its current valuation raises concerns, leading to the recommendation to hold the stock.
Rainbow Childrens Medicare, a notable player in the hospital and healthcare services sector, has recently experienced a revision in its evaluation by MarketsMOJO. This adjustment reflects a comprehensive analysis of the company's financial health and market position.The company has demonstrated impressive management efficiency, highlighted by a robust return on capital employed (ROCE) of 20.05%. This metric underscores Rainbow Childrens Medicare's capability to generate substantial profits from its capital investments. Furthermore, the firm maintains a low Debt to EBITDA ratio of 1.18 times, indicating a solid ability to manage and service its debt obligations effectively.
In terms of growth, Rainbow Childrens Medicare has reported a commendable annual operating profit growth rate of 28.61%. This positive trajectory was reinforced by the company's recent performance in September 2024, which marked a turnaround following two consecutive quarters of negative results.
From a technical perspective, the stock is currently positioned within a mildly bullish range, supported by various indicators such as MACD, Bollinger Bands, and KST, all suggesting a favorable trend. Additionally, the stock enjoys a significant institutional holding of 38.95%, reflecting confidence from larger investors who possess the resources to conduct thorough analyses of the company's fundamentals.
Over the past year, Rainbow Childrens Medicare has outperformed the broader market, achieving a return of 46.96% compared to the BSE 500's 25.55%. However, despite its strong performance, the stock is trading at a premium valuation, with an Enterprise Value to Capital Employed ratio of 10.2, which exceeds its historical averages. The company's profit growth has been modest at 7.5% over the past year, resulting in a PEG ratio of 9.6, suggesting that the stock may be trading at a discount relative to its historical valuations.
In light of these factors, Rainbow Childrens Medicare has been added to MarketsMOJO's list, indicating that investors should closely monitor the stock's future developments while holding their current positions. The company's promising growth and performance metrics suggest potential, but the current valuation and profit growth warrant a cautious approach.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
